AMGN - AMGEN INC
281.22
-2.560 -0.910%
Share volume: 4,537,310
Last Updated: 05-02-2025
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
0.00%
PREVIOUS CLOSE
CHG
CHG%
$283.78
-2.56
-0.01%
View ratios
| Fiscal Date | 06-30-2023 | 09-30-2023 | 12-31-2023 | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | |
| Report Date | 08-03-2023 | 10-31-2023 | 02-14-2025 | 05-02-2024 | 08-06-2024 | 10-30-2024 | 02-14-2025 | 05-01-2025 | |
| Total revenue | 6.986 B | 6.903 B | 8.196 B | 7.447 B | 8.388 B | 8.503 B | 9.086 B | 8.149 B | |
| Cost of revenue | 1.813 B | 1.806 B | 3.112 B | 3.200 B | 3.236 B | 3.310 B | 3.112 B | 2.968 B | |
| Gross profit | 5.173 B | 5.097 B | 5.084 B | 4.247 B | 5.152 B | 5.193 B | 5.974 B | 5.181 B | |
| -1.47% | -0.26% | -16.46% | 21.31% | 0.80% | 15.04% | -13.27% | |||
| Operating expenses | 2.407 B | 2.432 B | 4.687 B | 3.151 B | 3.232 B | 3.075 B | 3.850 B | 4.003 B | |
| Selling general and admin | 1.294 B | 1.353 B | 3.153 B | 1.808 B | 1.785 B | 1.625 B | 2.126 B | 2.517 B | |
| Research and development | 1.113 B | 1.079 B | 1.534 B | 1.343 B | 1.447 B | 1.450 B | 1.724 B | 1.486 B | |
| Total expenses | 2.489 B | 3.076 B | 3.813 B | 3.256 B | 3.243 B | 3.146 B | 3.663 B | 4.003 B | |
| 23.58% | 23.96% | -14.61% | -0.40% | -2.99% | 16.43% | 9.28% | |||
| Operating income | 2.684 B | 2.021 B | 1.271 B | 991.000 M | 1.909 B | 2.047 B | 2.311 B | 1.178 B | |
| Ebit | 2.366 B | 2.706 B | 1.673 B | 756.000 M | 1.602 B | 3.877 B | 1.529 B | 2.696 B | |
| Pretax income | 1.614 B | 1.947 B | 852.000 M | -68.000 M | 794.000 M | 3.101 B | 782.000 M | 1.973 B | |
| 20.63% | -56.24% | -107.98% | -1,267.65% | 290.55% | -74.78% | 152.30% | |||
| Income tax | 235.000 M | 217.000 M | 85.000 M | 45.000 M | 48.000 M | 271.000 M | 155.000 M | 243.000 M | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | 1.379 B | 1.730 B | 767.000 M | -113.000 M | 746.000 M | 2.830 B | 627.000 M | 1.730 B | |
| 25.45% | -55.66% | -114.73% | 760.18% | 279.36% | -77.84% | 175.92% |
